Cystic Fibrosis (CF) is a progressive, genetic disease of secretory glands affecting
approximately 30,000 people in the United States. The life expectancy of CF patients
has risen due to treatment advances, making preconception and contraceptive counseling
essential. Pregnancy is high risk in this population and dramatically impacts overall
health. Additionally, some CF medications are teratogenic or reduce the efficacy of
hormonal contraception. Barriers preventing adequate sexual and reproductive health
counseling include lack of time, knowledge, and discomfort with the subject. We sought
to evaluate counseling received and contraceptive use in female adolescent CF patients
at our institution.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Pediatric and Adolescent GynecologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
